| PTX | Paclitaxel |
| DEG(s) | Differentially expressed gene(s) |
| PCA | Principal Component Analysis |
| CDDP | Cisplatin |
| PPI | Protein-protein interaction network |
| IC50(120h) | Half maximal inhibitory concentration (for 120 h of drug treatment) |
| RI | Resistance index |
| SI | Sensitivity index |
| LMM | Linear mixed models |
| 95% CI | 95% confidential interval |
| NGS | Next generation sequencing |
| FDR | False discovery rate |
| q-value | FDR-adjusted p-value |
| PC | Principal Component |
| RNA-seq | RNA sequencing |
| FC | Fold change |
| GPCR(s) | G protein coupled receptor(s) |
| MSCs | Mesenchymal stem cells |
| CSCs | Cancer stem-like cells |
| ECM | Extracellular matrix |
| MT-MMPs | Membrane-type metalloproteinases |
| alamarBlue | aBlue |
| ECACC | European Collection of Authenticated Cell Cultures |
| PBS | Phosphate-buffered saline |
| RIN | RNA integrity number |
| GO | Gene Ontology |